Results 251 to 260 of about 77,949 (280)
Some of the next articles are maybe not open access.
[Carbapenem resistance in enterobacteria].
Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire +1 more source
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design, 2012Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A. +2 more
openaire +3 more sources
Screening for carbapenem-resistant bacteria
The Lancet Infectious Diseases, 2005James S, Soothill, Paul E, Lock
openaire +2 more sources
Colistin resistance in Carbapenem-resistant Klebsiella pneumoniae strains.
2016Objective: Because of the increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae; nowadays colistin is used more frequently. In this study, the firstly detected colistin resistance in carbapenem-resistant KPC-producing K. pneumoniae strains were evaluated.
Kalem F. +6 more
openaire +2 more sources
Artemisinin Resistance in Thailand; Carbapenem Resistance Spreading
Microbe Magazine, 2011Artemisinin-resistant malaria, seen along the border between Thailand and Cambodia, is “very worrying” and, if it spreads, could lead to a “disaster,” says Arjen Dondorp of the Mahidol-Oxford Research Unit in Bangkok, Thailand. Similarly, widespread resistance to carbapenems among gram-negative bacterial pathogens is a “hydra-headed threat,” says David
openaire +1 more source
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Nature Medicine, 2020Christoph M Ernst +2 more
exaly
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources
Regulation and biosynthesis of carbapenem antibiotics in bacteria
Nature Reviews Microbiology, 2005Sarah J Coulthurst, George P C Salmond
exaly

